A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

PHASE3UnknownINTERVENTIONAL
Timeline

Start Date

June 30, 1999

Conditions
Herpes SimplexHIV InfectionsHerpes Genitalis
Interventions
DRUG

Valacyclovir hydrochloride

Trial Locations (24)

19107

Philadelphia FIGHT, Philadelphia

23219

Richmond AIDS Consortium, Richmond

27610

Wake County Dept of Health, Raleigh

28207

Nalle Clinic / Clinical Research Dept, Charlotte

32701

IDC Research Initiative, Altamonte Springs

32960

Treasure Coast Infectious Disease Consultants, Vero Beach

33316

Healthnet Institute, Fort Lauderdale

33409

Palm Beach Research Ctr, West Palm Beach

46202

Indiana Univ School of Medicine / Dept of Infect Dis, Indianapolis

55455

Univ of Minnesota, Minneapolis

90036

Kraus Med Partners, Los Angeles

90211

Pacific Oaks Research, Beverly Hills

94109

ViRx Inc, San Francisco

94705

East Bay AIDS Ctr, Berkeley

97210

Westover Heights Clinic, Portland

98122

Univ of Washington Virology Research Clinic, Seattle

331361013

Univ of Miami School of Medicine, Miami

770303498

Baylor College of Medicine / Dept of Medicine, Houston

07601

Advanced Biomedical Research Inc, Hackensack

02907

Dr Alvan Fisher, Providence

Unknown

Dr Barbara Romanowski, Edmonton

Sunnybrook Health Science Ctr, Toronto

Clinique Medicale L'Actuele, Montreal

Centre De Recherche En Infectiologie, Ste Foy

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00005663 - A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients | Biotech Hunter | Biotech Hunter